Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Inventory Average (2016 - 2025)

Historic Inventory Average for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to $188.8 million.

  • Amphastar Pharmaceuticals' Inventory Average rose 4943.52% to $188.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $188.8 million, marking a year-over-year increase of 4943.52%. This contributed to the annual value of $129.8 million for FY2024, which is 2395.08% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Inventory Average stood at $188.8 million for Q3 2025, which was up 4943.52% from $188.6 million recorded in Q2 2025.
  • Amphastar Pharmaceuticals' 5-year Inventory Average high stood at $188.8 million for Q3 2025, and its period low was $94.0 million during Q1 2022.
  • Moreover, its 5-year median value for Inventory Average was $104.1 million (2023), whereas its average is $118.6 million.
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 1119.96% in 2021, then skyrocketed by 5855.36% in 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Inventory Average (Quarter) stood at $96.5 million in 2021, then increased by 7.14% to $103.4 million in 2022, then grew by 4.34% to $107.9 million in 2023, then soared by 31.62% to $142.0 million in 2024, then soared by 32.95% to $188.8 million in 2025.
  • Its Inventory Average was $188.8 million in Q3 2025, compared to $188.6 million in Q2 2025 and $169.6 million in Q1 2025.